CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO® Digital Health Platform. With over 1,100 devices in use globally, the pace of patient testing has accelerated with 100,000 patient […]

Bioimpedance Spectroscopy Technology Used by Hospitals and Large Oncology Groups as Part of Lymphedema Prevention Program Adds Heart Failure and Renal Disease Capabilities CARLSBAD, Calif., April 20, 2020 /PRNewswire/ — ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages […]

BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that two abstracts demonstrating utilization of its SOZO® device will be presented […]